Join Implicity at EHRA in Paris, France, April 12-14 We are thrilled to announce that Implicity will be exhibiting at the EHRA 2026 Congress, the annual meeting of the European Heart Rhythm Association. This flagship event will take place from April 12 to April 14, 2026, at the Palais des Congrès in Paris, France. EHRA is the world’s leading conference for electrophysiologists, arrhythmologists, and cardiac rhythm management professionals. For Implicity, this event is a homecoming where we share our latest innovations in AI-powered remote monitoring with the global EP community. Driving the Future of Digital Electrophysiology As the volume of data from pacemakers, ICDs, and ILRs continues to grow, the need for intelligent, vendor-neutral platforms has never been greater. Implicity remains dedicated to helping clinical teams move from « data management » to « patient management. » What to Expect at the Implicity Stand: The Power of One Platform: See how we integrate data from all major manufacturers—Abbott, Biotronik, Boston Scientific, Medtronic and Microport—into a single, high-performance dashboard. AI vs. Alert Fatigue: Discover how our CE-marked and FDA-cleared algorithms¹ filter out noise and prioritize clinically relevant events, reducing the workload for overstretched EP labs. Clinical Excellence: We will be presenting updated data and success stories on how remote monitoring improves long-term survival and reduces hospitalizations for heart failure and arrhythmia patients². A « City of Light » Meeting of the Minds The theme for EHRA 2026 focuses on « translating science into action. » This aligns perfectly with Implicity’s goal: taking complex raw data and turning it into actionable clinical insights that prevent adverse events and improve quality of life. « Hosting EHRA in Paris is always special for us. It’s the perfect setting to show how French-born innovation is helping EP teams around the world scale their remote monitoring programs without compromising patient safety. » — Dr. Arnaud Rosier, CEO & Co-founder of Implicity. Plan Your Visit Event: EHRA Congress 2026 Dates: April 12 – 14, 2026 Venue: Palais des Congrès de Paris (Porte Maillot) Connect With Us in Paris Will you be at EHRA 2026? We invite you to skip the lines and book a dedicated time for a demo or a deep dive into our clinical research with one of our experts. Schedule Your EHRA 2026 Demo Here ¹IM007 ILR ECG Analyzer (CE-marked Class I (under MDD) medical device) and SignalHF are FDA-cleared Class II medical devices, see the instructions for use for more information. ²Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.

Implicity Exhibiting at the DGK Annual Conference in Mannheim, Germany We are excited to announce that Implicity will be participating in the 92nd Annual Meeting of the German Society of Cardiology (DGK), held from April 8 to April 11, 2026, at the Rosengarten Congress Centre in Mannheim, Germany. As one of the premier events in European cardiovascular medicine, the DGK Annual Meeting brings together thousands of healthcare professionals to explore the latest breakthroughs in heart health. For Implicity, it is a vital opportunity to demonstrate how AI-driven remote monitoring is transforming the standard of care for patients with Cardiac Implantable Electronic Devices (CIEDs). Redefining the Patient Journey with AI At Implicity, our mission is to simplify the complexity of cardiac data. In an era where clinicians are often overwhelmed by « alert fatigue, » our universal remote monitoring platform serves as a critical filter—ensuring that the most urgent patient needs rise to the top. Why visit the Implicity booth in Mannheim? Universal Connectivity: Experience a single, streamlined interface that aggregates data from all major CIED manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic and Microport). Clinically Proven Impact: We will be sharing the latest real-world evidence from our EVIDENCE-RM study¹, which demonstrated a 26% reduction in all-cause mortality for patients managed through our platform. AI-Powered Efficiency: Learn how our FDA-cleared and CE-marked algorithms² significantly reduce false-positive alerts, allowing your team to focus on high-risk patients. Join the Conversation The theme of the DGK 2026 meeting centers on precision medicine and the integration of digital health into daily practice. Implicity is proud to be at the forefront of this shift, helping German « Telemonitoring-Zentren » (TMZs) and clinics worldwide optimize their workflows and improve patient outcomes. « The DGK conference is the heart of cardiology innovation in Germany. We look forward to meeting with our partners and showing how digital health tools can reduce physician workload while saving lives. » — Dr. Arnaud Rosier, CEO & Co-founder of Implicity. Event Details at a Glance Event: 92. Jahrestagung der Deutschen Gesellschaft für Kardiologie (DGK) Dates: April 8 – 11, 2026 Location: Congress Center Rosengarten, Mannheim, Germany Schedule a Private Demo Are you planning to attend DGK 2026? We would love to show you a personalized look at the Implicity platform. Book a Meeting with Our Team in Mannheim ¹Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024. ²IM007 ILR ECG Analyzer (CE-marked Class I (under MDD) medical device) and SignalHF are FDA-cleared Class II medical devices, see the instructions for use for more information.

Experience the Pulse of Innovation with Implicity at HRS 2026 in Chicago, IL We are proud to announce that Implicity will participate in Heart Rhythm 2026, the premier global event for the electrophysiology (EP) community. Join us from April 23 to April 26, 2026, in the vibrant city of Chicago, Illinois. The Heart Rhythm Society’s annual meeting is the world’s most significant gathering of heart rhythm professionals. For Implicity, it is a vital stage to demonstrate how our AI-driven remote monitoring platform is setting new standards for cardiac care in the United States and beyond. Bridging the Gap Between Data and Care In the fast-paced world of US healthcare, efficiency is everything. Implicity’s mission is to empower EP labs and clinics by turning the overwhelming tide of device data into clear, actionable clinical insights. Why visit Implicity at McCormick Place? A Unified View: See how our vendor-neutral platform seamlessly integrates data from Abbott, Biotronik, Boston Scientific, Medtronic and Microport into a single workflow. FDA-Cleared AI: Explore our advanced algorithms¹ designed to dramatically reduce false-positive alerts, allowing your team to focus on the patients who need intervention most. Proven Outcomes: We will be highlighting our latest clinical research, including the EVIDENCE-RM study², which proves that the right remote monitoring strategy can significantly reduce all-cause mortality. Transforming the EP Lab Workflow As the « Windy City » welcomes the brightest minds in cardiology, Implicity will be leading discussions on the integration of digital health and artificial intelligence into the modern clinic. Our goal is to help you scale your remote monitoring program while reducing physician burnout. « HRS Chicago is a landmark event for us. It’s where global innovation meets practical clinical application. We are excited to show the American EP community how our platform can double their monitoring capacity while improving patient safety. » — Dr. Arnaud Rosier, CEO & Co-founder of Implicity. Event Details Event: Heart Rhythm 2026 (HRS) Dates: April 23 – 26, 2026 Location: McCormick Place Convention Center, Chicago, IL, USA Meet Us in Chicago Planning your HRS itinerary? We invite you to schedule a one-on-one session with our clinical experts to see how Implicity can transform your practice. Book Your Private Demo at HRS 2026 ¹IM007 ILR ECG Analyzer (CE-marked Class I (under MDD) medical device) and SignalHF are FDA-cleared Class II medical devices, see the instructions for use for more information. ²Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.